Jubilant Pharmova Limited — Updates, 23-08-2026: General Updates
23-08-2026 | 12:49 am
23-08-2026 | 12:49 am
Jubilant Pharmova secured USFDA approval for commercial batch manufacturing on Line 3 at its Spokane, USA contract facility. This green light for the new isolator-based fill and finish line boosts capacity and operational readiness, signaling enhanced business potential.
No comments yet. Be the first to comment!
